Systematic review of diffuse hemispheric glioma, H3 G34-mutant: Outcomes and associated clinical factors.

ABSTRACT:

Background

A comprehensive review and description of the clinical features that impact prognosis for patients with diffuse hemispheric glioma, H3 G34-mutant (G34-DHG) is needed. Understanding survival and prognostic features is paramount for clinical advancements and patient care.

Methods

PubMed, Embase, and Google Scholar were searched for English articles published between January 1, 2012 and June 30, 2021. Eligible studies included patient(s) of any age diagnosed with an H3 G34-mutant brain tumor with at least one measure of survival or progression. Patient-level data were pooled for analyses. This study was prospectively registered in PROSPERO (CRD42021267764) and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed.

Results

SUBMITTER: Crowell C 

PROVIDER: S-EPMC9466272 | biostudies-literature | 2022 Jan-Dec

REPOSITORIES: biostudies-literature